Skip to main content
Clinical Trials/NCT03710473
NCT03710473
Completed
Not Applicable

Non-invasive and Continuous Monitoring of Diastolic Blood Pressure: a Prospective Observational Study - IMPACT

Insel Gruppe AG, University Hospital Bern1 site in 1 country90 target enrollmentApril 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Systemic Hypertension
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
90
Locations
1
Primary Endpoint
Comparison of diastolic blood pressures (in mmHg) assessed via non-invasive vs. invasive blood pressure (arterial line) measurement
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of the present study is to evaluate the accuracy of measuring beat-by-beat diastolic blood pressure from a non-invasive, cuffless and non-obtrusive watch-like optical device worn at the wrist.

Detailed Description

Given the prevalence of hypertension in society and the current limitations associated with oscillometric cuffs, the need for a continuous cuffless alternative for blood pressure home monitoring at a global scale is paramount. Such a device would not only improve the global control of blood pressure, but more generally, it could have a larger social impact by improving the comfort and reducing the stress for the clinical management of hypertensive patients. In the present study the investigators seek to investigate, as a primary purpose, to evaluate the accuracy of non-invasive blood pressure measurements via a watch-like optical sensor and compare these to standard monitoring (arterial line).

Registry
clinicaltrials.gov
Start Date
April 1, 2019
End Date
January 15, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Scheduled for cardiac or vascular surgery, with presence of a radial arterial line for perioperative management;
  • Willing and able to provide Informed Consent.

Exclusion Criteria

  • (Chronic) pace-maker/ defibrillator in situ at study inclusion;
  • Known severe aortic stenosis (mean gradient \> 40 mmHg, valve area \< 1 cm2);
  • Rhythmogenic heart disease (resting heart rate \> 120/min) at time of study inclusion;
  • Emergency patient (i.e. unscheduled OR).

Outcomes

Primary Outcomes

Comparison of diastolic blood pressures (in mmHg) assessed via non-invasive vs. invasive blood pressure (arterial line) measurement

Time Frame: 24 hours

Statistical comparison of both measures of diastolic blood pressure

Secondary Outcomes

  • Descriptive assessment: time until normalization of measurement after re-calibration of diastolic blood pressure measurement using the non-invasive approach(24 hours)
  • Descriptive analysis of comparison to measurements at the fingertip (non-invasive vs. fingertip diastolic blood pressure assessment)(24 hours)

Study Sites (1)

Loading locations...

Similar Trials